NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Entegrion

Entegrion

Private
Durham, North CarolinaHealthcare & Life Scienceshttps://entegrion.com/

Last Round

Series D

Jul 5, 2022

Total Funding Raised

$89.34M

Company Overview

Entegrion is a life sciences company that develops and manufactures diagnostic tools designed for the clinical diagnosis and management of hemostasis.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Defense Tech, Biotechnology, Clinical Trials

Business Model

B2G

Customer Profile

Government Contracts, Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

hemostasis managementcoagulation monitoringViscoelastic Coagulation MonitorVCMviscoelastic testingpoint-of-care testingPOC testingmilitary medicinemedical device manufacturertrauma diagnosticscombat casualty carecritical care diagnosticscoagulation analyzerdefense contractorveterinary diagnosticsgovernment contractsB2G

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Entegrion Comparables

Compare Entegrion with similar companies based on industry and business-model similarity.

Entegrion comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Perosphere Technologies Inc.
82%
Sienco, Inc.
81%
FloBio
79%

Entegrion Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DJul 5, 2022
GrantJul 31, 2012
GrantOct 4, 2011
GrantAug 25, 2011
Early FundingMar 31, 2011
Grant
Aug 6, 2009

Key People

Founding team and executive leadership

John Mowell

CEO - Chairman

Executive Team

Entegrion Investors

Notable investors and investment history

Entegrion investors
InvestorRounds
United States Department of DefenseGrant
Office of Naval ResearchGrant
U.S. NavyGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 17, 2026

    Monthly visitors grew 108% MoM.

  • Jan 7, 2026

    Monthly visitors increased 155% MoM.

Entegrion Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Entegrion Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Entegrion's valuation, stock price, and market status.

Firmographic Details

HeadquartersDurham, North Carolina
Employee Range13
Year Founded2002
Last FundingJul 5, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.